Implant Sciences [IMSC] 4Q14 4Q13 FY14 FY15 Sales $1.5M $2.4M $8.63M $12M Net Inc. ($5.7M, 0.09) ($5.5M, 0.10)($21M, 0.35) ($27.4M, 0.56) Losses in the quarter widened on lower sales, higher operating expenses and increased interest expense, partially offset by a $1.3 million decrease in stock-based compensation expense. Sales fell 36% due to a 40% decline in sales of the QS-B220 desktop explosives trace detector (ETD) and a 21% decline in the number of QS-H150 handheld ETD units sold.…
Recommended
Trending
Congress Updates
Build Of At Least 45 MQ-9s By Start Of FY 2029 Required By SASC Bill
Down to an inventory of 135 MQ-9A Reapers due to the loss of two dozen aircraft in strikes on Iran, the Air Force would have to field at least 45 […]
Kaine On Iranian Girls School Strike: “You Can Be Sure We’re Gonna Get The Answer To That One”
Sen. Timothy Kaine (D-Va.), the ranking member of the Senate Armed Services Committee (SASC) seapower panel, pledged on Tuesday that the Senate will get to the bottom of what happened […]
‘Right To Repair’ Reform In SASC’s FY ‘27 NDAA Sets “Government-Purpose Rights’ As Default
The “Right to Repair” provision secured in the Senate Armed Services Committee’s (SASC) version of the next defense policy bill would establish “government-purpose rights” as a default, requiring defense contractors […]
Pentagon May Make ‘Tradeoffs’ For Low-Cost Autonomous Tech Without Reconciliation Funds, CTO Says
The Pentagon’s chief technology officer has said the department may need to make “tradeoffs” on certain capability priorities if Congress doesn’t pass a reconciliation with $350 billion in requested defense […]
By